In addition, the immunologic profile in the revised criteria includes only anti-SSA/Ro antibodies, not ANA, RF, or anti-SSB/La antibodies.[19,20] As a result, there are some patients among those diagnosed with SS according to the 2012 ACR classification criteria who no longer meet the criteria for diagnosis according to the revised 2016 ACR-EULAR classification. The gene discussed is CALR; the disease is synovial sarcoma.